Short Interest in Precipio, Inc. (NASDAQ:PRPO) Drops By 15.6%

Precipio, Inc. (NASDAQ:PRPO) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 2,700 shares, a decline of 15.6% from the December 15th total of 3,200 shares. Based on an average daily trading volume, of 7,100 shares, the days-to-cover ratio is currently 0.4 days. Currently, 0.2% of the company’s shares are short sold.

Precipio Trading Up 0.8 %

Precipio stock traded up $0.05 during trading hours on Thursday, reaching $6.15. The stock had a trading volume of 4,212 shares, compared to its average volume of 8,931. The company has a fifty day simple moving average of $5.86 and a 200-day simple moving average of $5.93. Precipio has a 52 week low of $4.31 and a 52 week high of $7.30. The stock has a market cap of $9.10 million, a PE ratio of -3.36 and a beta of 1.41. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.73 and a quick ratio of 0.60.

Precipio Company Profile

Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.